3020B |
Methylphenidate and Metabolite, Blood |
3020SP |
Methylphenidate and Metabolite, Serum/Plasma |
3020TI |
Methylphenidate and Metabolite, Tissue |
3020U |
Methylphenidate and Metabolite, Urine |
3041B |
Metoclopramide, Blood |
3041SP |
Metoclopramide, Serum/Plasma |
3041U |
Metoclopramide, Urine |
3042B |
Metolazone, Blood |
3042SP |
Metolazone, Serum/Plasma |
3043B |
Metoprolol, Blood |
3043FL |
Metoprolol, Fluid |
3043SP |
Metoprolol, Serum/Plasma |
3043U |
Metoprolol, Urine |
3045B |
Modafinil / Armodafinil, Blood |
3045SP |
Modafinil / Armodafinil, Serum/Plasma |
3050B |
Metronidazole, Blood |
3050SP |
Metronidazole, Serum/Plasma |
3057B |
Midazolam, Blood |
3057FL |
Midazolam, Fluid |
3057SP |
Midazolam, Serum/Plasma |
3057U |
Midazolam as Metabolite, Urine |
3061B |
Milnacipran/Levomilnacipran, Blood |
3061SP |
Milnacipran/Levomilnacipran, Serum/Plasma |
3061U |
Milnacipran/Levomilnacipran, Urine |
3063B |
Mycophenolic Acid and Metabolite, Blood |
3063SP |
Mycophenolic Acid and Metabolite, Serum/Plasma |
3063U |
Mycophenolic Acid and Metabolite, Urine |
3064B |
Mitragynine, Blood |
3064SP |
Mitragynine, Serum/Plasma |
3078U |
Mitragynine (Qualitative), Urine |
3082B |
Molindone, Blood |
3082SP |
Molindone, Serum/Plasma |
3082U |
Molindone, Urine |
3085B |
Morphine and Glucuronide Metabolites, Blood |
3085SP |
Morphine and Glucuronide Metabolites, Serum/Plasma |
3092SP |
Moricizine, Serum/Plasma |
3098U |
Mono-n-butyl phthalate (MNBP), Urine |
3099U |
Phthalates Panel, Urine |
3103B |
Nadolol, Blood |
3103SP |
Nadolol, Serum/Plasma |
3103U |
Nadolol, Urine |
3107B |
Nabumetone as Metabolite, Blood |
3107SP |
Nabumetone as Metabolite, Serum/Plasma |
3107U |
Nabumetone as Metabolite, Urine |
3110B |
Nalbuphine - Free (Unconjugated), Blood |
3110SP |
Nalbuphine - Free (Unconjugated), Serum/Plasma |
3110U |
Nalbuphine - Total (Conjugated/Unconjugated), Urine |
3111B |
Naloxone - Free (Unconjugated), Blood |
3111SP |
Naloxone - Free (Unconjugated), Serum/Plasma |
3111U |
Naloxone - Total (Conjugated/Unconjugated), Urine |
3113U |
Naloxone - Total (Conjugated/Unconjugated) Screen, Urine |
3116B |
Naltrexone and Metabolite - Free (Unconjugated), Blood |
3116SP |
Naltrexone and Metabolite - Free (Unconjugated), Serum/Plasma |
3116U |
Naltrexone and Metabolite - Total (Conjugated/Unconjugated), Urine |
3118B |
Nateglinide, Blood |
3118SP |
Nateglinide, Serum/Plasma |
3124SP |
1-Naphthol, Serum/Plasma |
3130B |
Naproxen, Blood |
3130FL |
Naproxen, Fluid |
3130SP |
Naproxen, Serum/Plasma |
3130U |
Naproxen, Urine |
3145B |
Nefazodone, Blood |
3145SP |
Nefazodone, Serum/Plasma |
3145U |
Nefazodone, Urine |
3150B |
Nicotine and Metabolite, Blood |
3150FL |
Nicotine and Metabolite, Fluid |
3150SP |
Nicotine and Metabolite, Serum/Plasma |
3150TI |
Nicotine and Metabolite, Tissue |
3150U |
Nicotine and Metabolite with Anabasine, Urine |
3157U |
Cotinine and Anabasine from Secondary Exposure, Urine |
3158B |
Nifedipine, Blood |
3158SP |
Nifedipine, Serum/Plasma |
3168B |
Nitazenes Panel, Blood |
3168SP |
Nitazenes Panel, Serum/Plasma |
3175B |
Nitrazepam and Metabolite, Blood |
3175SP |
Nitrazepam and Metabolite, Serum/Plasma |
3175U |
Nitrazepam and Metabolite, Urine |
3216B |
Nordiazepam and Metabolite, Blood |
3216SP |
Nordiazepam and Metabolite, Serum/Plasma |
3216U |
Nordiazepam and Metabolite, Urine |
3218B |
N,N-Dimethylpentylone & Pentylone, Blood |
3218SP |
N,N-Dimethylpentylone & Pentylone, Serum/Plasma |
3218U |
N,N-Dimethylpentylone & Pentylone, Urine |
3223SP |
Nonsteroidal Anti-Inflammatory Drug Panel, Serum/Plasma |
3224B |
NPS Stimulants (Qualitative), Blood |
3224SP |
NPS Stimulants (Qualitative), Serum/Plasma |
3224U |
NPS Stimulants (Qualitative), Urine |
3225SP |
Nuedexta®, Serum/Plasma |
3226B |
Olanzapine and Metabolite, Blood |
3226FL |
Olanzapine, Fluid |
3226SP |
Olanzapine and Metabolite, Serum/Plasma |
3226TI |
Olanzapine, Tissue |
3227B |
Beta-Blockers Panel, Blood |
3227SP |
Beta-Blockers Panel, Serum/Plasma |
3227U |
Beta-Blockers Panel, Urine |
3232B |
Omeprazole / Esomeprazole, Blood |
3232SP |
Omeprazole / Esomeprazole, Serum/Plasma |
3241B |
Opiates - Free (Unconjugated), Blood |
3250SP |
Oxalate, Serum/Plasma |
3260B |
Oxazepam, Blood |
3260SP |
Oxazepam, Serum/Plasma |
3260U |
Oxazepam, Urine |
3265B |
Oxcarbazepine / Eslicarbazepine Acetate as Metabolite, Blood |
3265SP |
Oxcarbazepine / Eslicarbazepine Acetate as Metabolite, Serum/Plasma |
3266B |
Oxybutynin and Metabolite, Blood |
3266SP |
Oxybutynin and Metabolite, Serum/Plasma |
3266U |
Oxybutynin and Metabolite, Urine |
3270B |
Oxycodone - Free (Unconjugated), Blood |
3270FL |
Oxycodone - Free (Unconjugated), Fluid |
3270SP |
Oxycodone - Free (Unconjugated), Serum/Plasma |
3286B |
Oxaprozin, Blood |
3286SP |
Oxaprozin, Serum/Plasma |
3325B |
Paraquat, Blood |
3325SP |
Paraquat, Serum/Plasma |
3360B |
Paroxetine, Blood |
3360FL |
Paroxetine, Fluid |
3360SP |
Paroxetine, Serum/Plasma |
3360TI |
Paroxetine, Tissue |
3360U |
Paroxetine, Urine |
3371SP |
PCB Panel, Congeners, Serum/Plasma |
3381SP |
Penciclovir, Serum/Plasma |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3433SP |
Perampanel, Serum/Plasma |
3436B |
Percodan®, Blood |
3436SP |
Percodan®, Serum/Plasma |
3440B |
Perphenazine, Blood |
3440SP |
Perphenazine, Serum/Plasma |
3475U |
S-Phenylmercapturic Acid, Urine |
3510B |
Phenacetin and Metabolite, Blood |
3510U |
Phenacetin and Metabolite, Urine |
3580B |
Phenobarbital, Blood |
3580SP |
Phenobarbital, Serum/Plasma |
3581SP |
Phenobarbital - Unbound, Serum/Plasma |
3582SP |
Phenobarbital - Total/Unbound/Bound, Serum/Plasma |
3690B |
Phentermine, Blood |
3690SP |
Phentermine, Serum/Plasma |
3690U |
Phentermine, Urine |
3704SP |
Phenylephrine, Serum/Plasma |
3707B |
Phenylethylmalonamide, Blood |
3707SP |
Phenylethylmalonamide, Serum/Plasma |
3720B |
Phenylpropanolamine, Blood |
3720SP |
Phenylpropanolamine, Serum/Plasma |
3720U |
Phenylpropanolamine, Urine |
3743B |
Phenytoin, Blood |
3743FL |
Phenytoin, Fluid |
3743SP |
Phenytoin, Serum/Plasma |
3743TI |
Phenytoin, Tissue |
3752B |
Phosphatidylethanol, Blood |
3776B |
Pimozide, Blood |
3776SP |
Pimozide, Serum/Plasma |
3779B |
Pioglitazone, Blood |
3779SP |
Pioglitazone, Serum/Plasma |
3781B |
Piroxicam, Blood |
3781SP |
Piroxicam, Serum/Plasma |
3781U |
Piroxicam, Urine |
3788B |
Prazosin, Blood |
3788SP |
Prazosin, Serum/Plasma |
3790B |
Posaconazole, Blood |
3790SP |
Posaconazole, Serum/Plasma |
3795B |
Pregabalin, Blood |
3795SP |
Pregabalin, Serum/Plasma |
3795U |
Pregabalin, Urine |
3900B |
Primidone, Phenobarbital and PEMA, Blood |
3900FL |
Primidone, Phenobarbital and PEMA, Fluid |
3900SP |
Primidone, Phenobarbital and PEMA, Serum/Plasma |
3901SP |
Primidone, Serum/Plasma |
3950B |
Prochlorperazine, Blood |
3950SP |
Prochlorperazine, Serum/Plasma |
3970B |
Promethazine, Blood |
3970SP |
Promethazine, Serum/Plasma |
3970TI |
Promethazine, Tissue |
3970U |
Promethazine, Urine |
3976B |
Propafenone, Blood |
3976SP |
Propafenone, Serum/Plasma |